| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Echocardiography | 182 | 2024 | 5037 | 4.680 |
Why?
|
| Cardiomyopathy, Hypertrophic | 45 | 2023 | 1336 | 3.570 |
Why?
|
| Heart Ventricles | 95 | 2023 | 3832 | 3.310 |
Why?
|
| Cardiomyopathy, Dilated | 42 | 2024 | 843 | 3.290 |
Why?
|
| Heart Defects, Congenital | 97 | 2024 | 4712 | 2.980 |
Why?
|
| Ventricular Function, Left | 85 | 2024 | 3935 | 2.900 |
Why?
|
| Myocardial Contraction | 62 | 2020 | 1516 | 2.790 |
Why?
|
| Ventricular Dysfunction, Left | 45 | 2020 | 2143 | 2.450 |
Why?
|
| Aortic Valve Insufficiency | 23 | 2023 | 575 | 2.370 |
Why?
|
| Echocardiography, Doppler | 38 | 2024 | 899 | 2.320 |
Why?
|
| Heart | 45 | 2023 | 4425 | 1.800 |
Why?
|
| Cardiomyopathies | 27 | 2024 | 2059 | 1.650 |
Why?
|
| Sarcomeres | 15 | 2020 | 379 | 1.600 |
Why?
|
| Heart Transplantation | 36 | 2022 | 3306 | 1.440 |
Why?
|
| Transposition of Great Vessels | 27 | 2023 | 581 | 1.390 |
Why?
|
| Aortic Valve Stenosis | 31 | 2020 | 2023 | 1.330 |
Why?
|
| Infant | 216 | 2023 | 36461 | 1.310 |
Why?
|
| Hypertrophy, Left Ventricular | 24 | 2023 | 856 | 1.310 |
Why?
|
| Child, Preschool | 221 | 2023 | 42577 | 1.300 |
Why?
|
| Ventricular Remodeling | 22 | 2024 | 1281 | 1.270 |
Why?
|
| Child | 273 | 2024 | 80668 | 1.250 |
Why?
|
| Cardiac Surgical Procedures | 34 | 2023 | 3684 | 1.220 |
Why?
|
| Antibiotics, Antineoplastic | 11 | 2023 | 678 | 1.180 |
Why?
|
| Doxorubicin | 16 | 2023 | 2229 | 1.170 |
Why?
|
| Mucocutaneous Lymph Node Syndrome | 15 | 2015 | 538 | 1.060 |
Why?
|
| Diastole | 28 | 2022 | 784 | 1.040 |
Why?
|
| Fontan Procedure | 20 | 2018 | 805 | 1.020 |
Why?
|
| Heart Septal Defects, Ventricular | 21 | 2023 | 477 | 0.950 |
Why?
|
| Infant, Newborn | 140 | 2023 | 26389 | 0.930 |
Why?
|
| Adolescent | 198 | 2023 | 88904 | 0.890 |
Why?
|
| Body Surface Area | 8 | 2021 | 206 | 0.880 |
Why?
|
| Heart Valve Diseases | 10 | 2023 | 1029 | 0.830 |
Why?
|
| Registries | 40 | 2024 | 8351 | 0.830 |
Why?
|
| Heart Atria | 15 | 2023 | 1361 | 0.810 |
Why?
|
| Aortic Diseases | 9 | 2023 | 741 | 0.810 |
Why?
|
| Hypoplastic Left Heart Syndrome | 13 | 2014 | 595 | 0.790 |
Why?
|
| Heart Diseases | 20 | 2024 | 2817 | 0.780 |
Why?
|
| Stroke Volume | 49 | 2024 | 5618 | 0.760 |
Why?
|
| Mitral Valve Insufficiency | 12 | 2023 | 1414 | 0.740 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 13 | 2023 | 1560 | 0.730 |
Why?
|
| Heart Failure | 30 | 2024 | 11882 | 0.700 |
Why?
|
| Heart Bypass, Right | 7 | 2017 | 75 | 0.670 |
Why?
|
| Magnetic Resonance Imaging, Cine | 15 | 2023 | 1089 | 0.670 |
Why?
|
| Isolated Noncompaction of the Ventricular Myocardium | 3 | 2018 | 22 | 0.670 |
Why?
|
| Cardiac Volume | 9 | 2018 | 196 | 0.660 |
Why?
|
| Aortic Coarctation | 11 | 2013 | 278 | 0.650 |
Why?
|
| Death, Sudden, Cardiac | 11 | 2022 | 1567 | 0.650 |
Why?
|
| Ventricular Function | 17 | 2017 | 403 | 0.650 |
Why?
|
| Ventricular Outflow Obstruction | 10 | 2020 | 262 | 0.650 |
Why?
|
| Humans | 469 | 2024 | 766766 | 0.650 |
Why?
|
| Pulmonary Artery | 19 | 2013 | 1938 | 0.630 |
Why?
|
| Postoperative Complications | 40 | 2021 | 15831 | 0.620 |
Why?
|
| Hemodynamics | 35 | 2015 | 4188 | 0.620 |
Why?
|
| Heart Septal Defects, Atrial | 9 | 2022 | 452 | 0.620 |
Why?
|
| Anti-Retroviral Agents | 4 | 2020 | 1787 | 0.610 |
Why?
|
| Male | 281 | 2024 | 364142 | 0.610 |
Why?
|
| Echocardiography, Three-Dimensional | 7 | 2018 | 611 | 0.600 |
Why?
|
| Adrenergic beta-Antagonists | 11 | 2018 | 1241 | 0.600 |
Why?
|
| American Heart Association | 4 | 2023 | 1049 | 0.590 |
Why?
|
| Maternal-Fetal Exchange | 2 | 2020 | 453 | 0.590 |
Why?
|
| Female | 293 | 2024 | 396520 | 0.580 |
Why?
|
| Myocardium | 24 | 2023 | 4765 | 0.580 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 6 | 2020 | 428 | 0.570 |
Why?
|
| Pulmonary Valve Stenosis | 6 | 2023 | 164 | 0.570 |
Why?
|
| Dilatation, Pathologic | 18 | 2023 | 527 | 0.570 |
Why?
|
| Terminology as Topic | 12 | 2018 | 1540 | 0.570 |
Why?
|
| Arrhythmias, Cardiac | 15 | 2020 | 2258 | 0.550 |
Why?
|
| Pulmonary Atresia | 5 | 2023 | 159 | 0.550 |
Why?
|
| Tricuspid Valve Insufficiency | 4 | 2020 | 361 | 0.540 |
Why?
|
| Systole | 25 | 2019 | 935 | 0.540 |
Why?
|
| Atenolol | 5 | 2020 | 99 | 0.540 |
Why?
|
| Cardiomyopathy, Restrictive | 4 | 2023 | 61 | 0.530 |
Why?
|
| Pregnancy Complications, Infectious | 7 | 2020 | 2184 | 0.520 |
Why?
|
| Razoxane | 3 | 2012 | 43 | 0.520 |
Why?
|
| Norwood Procedures | 6 | 2016 | 192 | 0.510 |
Why?
|
| Pediatrics | 20 | 2021 | 3614 | 0.510 |
Why?
|
| Cardiac Myosins | 5 | 2020 | 128 | 0.500 |
Why?
|
| Anthracyclines | 7 | 2024 | 286 | 0.490 |
Why?
|
| Catheterization | 9 | 2010 | 1429 | 0.490 |
Why?
|
| Body Height | 5 | 2021 | 1562 | 0.490 |
Why?
|
| Follow-Up Studies | 81 | 2023 | 39309 | 0.480 |
Why?
|
| Cardiomegaly | 12 | 2021 | 591 | 0.480 |
Why?
|
| Retrospective Studies | 107 | 2023 | 81635 | 0.480 |
Why?
|
| Iron Overload | 4 | 2023 | 245 | 0.480 |
Why?
|
| Losartan | 5 | 2020 | 263 | 0.480 |
Why?
|
| HIV Infections | 28 | 2020 | 17536 | 0.480 |
Why?
|
| Body Size | 3 | 2022 | 461 | 0.480 |
Why?
|
| Cardiology | 9 | 2024 | 1701 | 0.470 |
Why?
|
| Myosin Heavy Chains | 5 | 2020 | 403 | 0.460 |
Why?
|
| Aortic Valve | 13 | 2018 | 1966 | 0.460 |
Why?
|
| Enalapril | 4 | 2019 | 317 | 0.460 |
Why?
|
| Young Adult | 72 | 2024 | 59939 | 0.450 |
Why?
|
| Mitral Valve | 10 | 2023 | 1473 | 0.430 |
Why?
|
| Prospective Studies | 76 | 2023 | 54871 | 0.430 |
Why?
|
| Atrial Function, Left | 3 | 2017 | 188 | 0.420 |
Why?
|
| Aorta, Thoracic | 9 | 2023 | 1110 | 0.420 |
Why?
|
| Treatment Outcome | 88 | 2024 | 65273 | 0.420 |
Why?
|
| Coronary Vessels | 14 | 2013 | 3100 | 0.420 |
Why?
|
| Models, Cardiovascular | 6 | 2015 | 978 | 0.410 |
Why?
|
| International Classification of Diseases | 5 | 2021 | 935 | 0.410 |
Why?
|
| Antiretroviral Therapy, Highly Active | 7 | 2018 | 1900 | 0.400 |
Why?
|
| Reproducibility of Results | 36 | 2023 | 20144 | 0.400 |
Why?
|
| Image Interpretation, Computer-Assisted | 4 | 2018 | 3359 | 0.400 |
Why?
|
| Graft Rejection | 4 | 2020 | 4504 | 0.400 |
Why?
|
| Risk Factors | 76 | 2023 | 74881 | 0.400 |
Why?
|
| Carotid Arteries | 3 | 2014 | 932 | 0.390 |
Why?
|
| Ventricular Pressure | 7 | 2019 | 210 | 0.390 |
Why?
|
| HIV Seropositivity | 3 | 2013 | 962 | 0.380 |
Why?
|
| Marfan Syndrome | 4 | 2018 | 237 | 0.380 |
Why?
|
| Reference Values | 16 | 2023 | 4913 | 0.380 |
Why?
|
| Survivors | 9 | 2023 | 2379 | 0.380 |
Why?
|
| Biometry | 2 | 2013 | 571 | 0.370 |
Why?
|
| Societies, Medical | 11 | 2021 | 3957 | 0.360 |
Why?
|
| Cardiotoxins | 3 | 2017 | 36 | 0.360 |
Why?
|
| Aorta | 14 | 2018 | 2043 | 0.360 |
Why?
|
| Ventricular Function, Right | 6 | 2018 | 629 | 0.350 |
Why?
|
| Time Factors | 60 | 2019 | 40149 | 0.350 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 7 | 2011 | 1514 | 0.340 |
Why?
|
| Adult | 121 | 2024 | 223307 | 0.330 |
Why?
|
| Cardiotonic Agents | 6 | 2016 | 541 | 0.330 |
Why?
|
| Zidovudine | 3 | 2012 | 625 | 0.330 |
Why?
|
| Heart Septum | 9 | 2020 | 303 | 0.330 |
Why?
|
| Heart Septal Defects | 5 | 2017 | 191 | 0.320 |
Why?
|
| Amlodipine | 3 | 2023 | 84 | 0.320 |
Why?
|
| Coronary Vessel Anomalies | 9 | 1999 | 308 | 0.320 |
Why?
|
| Hypertrophy, Right Ventricular | 3 | 2000 | 109 | 0.320 |
Why?
|
| Risk Assessment | 34 | 2023 | 24295 | 0.310 |
Why?
|
| beta-Thalassemia | 2 | 2023 | 234 | 0.310 |
Why?
|
| Immunoglobulins, Intravenous | 5 | 2010 | 668 | 0.310 |
Why?
|
| Noonan Syndrome | 3 | 2023 | 122 | 0.310 |
Why?
|
| Death, Sudden | 1 | 2010 | 301 | 0.310 |
Why?
|
| Cardiovascular System | 3 | 2004 | 839 | 0.310 |
Why?
|
| Cardiovascular Agents | 3 | 2010 | 849 | 0.300 |
Why?
|
| Ultrasonography | 21 | 2013 | 5992 | 0.300 |
Why?
|
| Age Factors | 33 | 2020 | 18397 | 0.300 |
Why?
|
| Canada | 10 | 2019 | 2126 | 0.290 |
Why?
|
| Tetralogy of Fallot | 4 | 2023 | 629 | 0.290 |
Why?
|
| Genetic Testing | 5 | 2022 | 3591 | 0.290 |
Why?
|
| Incidence | 33 | 2022 | 21525 | 0.280 |
Why?
|
| Organ Size | 9 | 2022 | 2261 | 0.280 |
Why?
|
| Natriuretic Peptide, Brain | 9 | 2018 | 1750 | 0.280 |
Why?
|
| Survival Rate | 26 | 2021 | 12825 | 0.280 |
Why?
|
| Predictive Value of Tests | 28 | 2023 | 15416 | 0.280 |
Why?
|
| Echocardiography, Stress | 3 | 2020 | 137 | 0.270 |
Why?
|
| Health Status | 11 | 2018 | 4087 | 0.270 |
Why?
|
| Infectious Disease Transmission, Vertical | 11 | 2015 | 1354 | 0.270 |
Why?
|
| Muscular Dystrophy, Duchenne | 2 | 2008 | 271 | 0.270 |
Why?
|
| Propanolamines | 3 | 2016 | 164 | 0.260 |
Why?
|
| Practice Guidelines as Topic | 8 | 2022 | 7431 | 0.260 |
Why?
|
| Boston | 17 | 2023 | 9346 | 0.260 |
Why?
|
| Calcium Channel Blockers | 5 | 2023 | 687 | 0.260 |
Why?
|
| Blood Pressure | 19 | 2019 | 8533 | 0.260 |
Why?
|
| Lung Transplantation | 1 | 2015 | 1310 | 0.250 |
Why?
|
| Electrocardiography | 28 | 2018 | 6408 | 0.250 |
Why?
|
| Waiting Lists | 2 | 2012 | 779 | 0.250 |
Why?
|
| Fetal Heart | 6 | 2006 | 281 | 0.250 |
Why?
|
| Aortic Aneurysm | 3 | 2015 | 649 | 0.250 |
Why?
|
| Troponin T | 6 | 2018 | 786 | 0.250 |
Why?
|
| Exercise Test | 15 | 2022 | 2188 | 0.240 |
Why?
|
| Ventricular Dysfunction | 4 | 2016 | 143 | 0.240 |
Why?
|
| Algorithms | 7 | 2020 | 14072 | 0.240 |
Why?
|
| Genotype | 13 | 2022 | 13036 | 0.240 |
Why?
|
| Carbazoles | 3 | 2016 | 230 | 0.240 |
Why?
|
| Prognosis | 37 | 2023 | 29948 | 0.240 |
Why?
|
| United States | 44 | 2024 | 72951 | 0.240 |
Why?
|
| Vascular Surgical Procedures | 4 | 2012 | 1506 | 0.240 |
Why?
|
| Cardiopulmonary Bypass | 2 | 2002 | 1097 | 0.240 |
Why?
|
| Disease Progression | 25 | 2022 | 13640 | 0.230 |
Why?
|
| Phenotype | 20 | 2023 | 16724 | 0.230 |
Why?
|
| Pulmonary Valve | 11 | 2016 | 413 | 0.230 |
Why?
|
| Severity of Illness Index | 19 | 2020 | 15908 | 0.230 |
Why?
|
| Tachycardia, Supraventricular | 6 | 2007 | 272 | 0.230 |
Why?
|
| Reoperation | 15 | 2023 | 4325 | 0.230 |
Why?
|
| Multivariate Analysis | 22 | 2017 | 12064 | 0.230 |
Why?
|
| Mutation | 15 | 2021 | 30213 | 0.230 |
Why?
|
| Kaplan-Meier Estimate | 13 | 2018 | 6512 | 0.230 |
Why?
|
| Aftercare | 4 | 2022 | 915 | 0.230 |
Why?
|
| Sensitivity and Specificity | 22 | 2016 | 14652 | 0.220 |
Why?
|
| HIV | 2 | 2011 | 1588 | 0.220 |
Why?
|
| Blood Flow Velocity | 9 | 2016 | 1374 | 0.220 |
Why?
|
| Databases, Factual | 10 | 2021 | 8066 | 0.220 |
Why?
|
| Survival Analysis | 15 | 2015 | 10100 | 0.220 |
Why?
|
| Maternal Exposure | 2 | 2011 | 1097 | 0.220 |
Why?
|
| Mutation, Missense | 4 | 2021 | 2590 | 0.220 |
Why?
|
| ROC Curve | 10 | 2020 | 3620 | 0.220 |
Why?
|
| LEOPARD Syndrome | 1 | 2023 | 12 | 0.220 |
Why?
|
| Triiodothyronine | 4 | 2016 | 493 | 0.220 |
Why?
|
| Heart Valves | 3 | 2020 | 284 | 0.220 |
Why?
|
| Vena Cava, Superior | 2 | 2006 | 197 | 0.220 |
Why?
|
| Patient Care Management | 3 | 2011 | 302 | 0.210 |
Why?
|
| Human Growth Hormone | 2 | 2005 | 640 | 0.210 |
Why?
|
| Cardiography, Impedance | 1 | 2003 | 40 | 0.210 |
Why?
|
| Proportional Hazards Models | 17 | 2020 | 12534 | 0.210 |
Why?
|
| Foramen Ovale | 1 | 2022 | 17 | 0.210 |
Why?
|
| Prenatal Exposure Delayed Effects | 4 | 2015 | 2538 | 0.210 |
Why?
|
| Adrenergic beta-1 Receptor Antagonists | 2 | 2020 | 30 | 0.210 |
Why?
|
| Truncus Arteriosus, Persistent | 1 | 2023 | 63 | 0.200 |
Why?
|
| Endocardium | 3 | 2000 | 249 | 0.200 |
Why?
|
| Cohort Studies | 34 | 2022 | 41710 | 0.200 |
Why?
|
| Musculoskeletal Abnormalities | 1 | 2003 | 101 | 0.200 |
Why?
|
| Single-Blind Method | 4 | 2017 | 1587 | 0.200 |
Why?
|
| Atrial Septum | 1 | 2022 | 61 | 0.200 |
Why?
|
| Anthropometry | 3 | 2004 | 1336 | 0.200 |
Why?
|
| Thalassemia | 3 | 2014 | 267 | 0.200 |
Why?
|
| Mortality | 3 | 2020 | 2910 | 0.200 |
Why?
|
| Image Enhancement | 4 | 2016 | 2857 | 0.200 |
Why?
|
| Progeria | 1 | 2024 | 182 | 0.190 |
Why?
|
| Ultrasonography, Prenatal | 9 | 2013 | 1772 | 0.190 |
Why?
|
| Cross-Sectional Studies | 28 | 2018 | 26310 | 0.190 |
Why?
|
| Consensus | 3 | 2018 | 3208 | 0.190 |
Why?
|
| Observer Variation | 6 | 2017 | 2614 | 0.190 |
Why?
|
| Atrial Fibrillation | 6 | 2021 | 5182 | 0.190 |
Why?
|
| Myocytes, Cardiac | 3 | 2020 | 1673 | 0.190 |
Why?
|
| Double Outlet Right Ventricle | 4 | 2010 | 60 | 0.190 |
Why?
|
| Glycogen Storage Disease Type II | 1 | 2021 | 43 | 0.190 |
Why?
|
| Heart Function Tests | 4 | 2012 | 316 | 0.190 |
Why?
|
| Length of Stay | 14 | 2019 | 6490 | 0.190 |
Why?
|
| Morbidity | 7 | 2021 | 1754 | 0.180 |
Why?
|
| Aortic Aneurysm, Thoracic | 3 | 2012 | 708 | 0.180 |
Why?
|
| Quality Improvement | 7 | 2018 | 3850 | 0.180 |
Why?
|
| Tricuspid Valve | 10 | 2018 | 419 | 0.180 |
Why?
|
| Genetic Predisposition to Disease | 14 | 2023 | 18075 | 0.180 |
Why?
|
| Cardiovascular Diseases | 8 | 2021 | 15657 | 0.180 |
Why?
|
| Cardiology Service, Hospital | 3 | 2011 | 242 | 0.180 |
Why?
|
| Pregnancy | 24 | 2020 | 30237 | 0.180 |
Why?
|
| Quality Indicators, Health Care | 4 | 2015 | 1804 | 0.180 |
Why?
|
| Defibrillators, Implantable | 5 | 2020 | 1499 | 0.170 |
Why?
|
| Fibrosis | 9 | 2023 | 2077 | 0.170 |
Why?
|
| Clinical Competence | 6 | 2016 | 4858 | 0.170 |
Why?
|
| Exercise | 7 | 2012 | 5945 | 0.170 |
Why?
|
| Inheritance Patterns | 1 | 2022 | 345 | 0.170 |
Why?
|
| Myocarditis | 7 | 2012 | 802 | 0.160 |
Why?
|
| Preoperative Care | 7 | 2003 | 2253 | 0.160 |
Why?
|
| Longitudinal Studies | 17 | 2018 | 14762 | 0.160 |
Why?
|
| Coronary Circulation | 6 | 2016 | 1602 | 0.160 |
Why?
|
| Pulmonary Veins | 4 | 2011 | 758 | 0.160 |
Why?
|
| Iron | 4 | 2023 | 1812 | 0.160 |
Why?
|
| Osteosarcoma | 2 | 2023 | 908 | 0.160 |
Why?
|
| Pulse | 4 | 2009 | 217 | 0.160 |
Why?
|
| Patient Discharge | 5 | 2022 | 3465 | 0.160 |
Why?
|
| Linear Models | 12 | 2018 | 5874 | 0.150 |
Why?
|
| Scoliosis | 3 | 2003 | 793 | 0.150 |
Why?
|
| Aging | 7 | 2024 | 8731 | 0.150 |
Why?
|
| Life Tables | 5 | 2006 | 367 | 0.150 |
Why?
|
| Dobutamine | 4 | 1992 | 114 | 0.150 |
Why?
|
| Mitral Valve Stenosis | 4 | 2023 | 342 | 0.150 |
Why?
|
| Hospitals, Pediatric | 6 | 2016 | 1851 | 0.150 |
Why?
|
| Electric Countershock | 2 | 2020 | 534 | 0.150 |
Why?
|
| Oxygen Consumption | 3 | 2016 | 1874 | 0.150 |
Why?
|
| Postoperative Period | 10 | 2018 | 1824 | 0.150 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2004 | 643 | 0.150 |
Why?
|
| Atrial Function | 1 | 2018 | 98 | 0.150 |
Why?
|
| Chelation Therapy | 1 | 2018 | 76 | 0.150 |
Why?
|
| Genetic Variation | 4 | 2022 | 6612 | 0.150 |
Why?
|
| Echocardiography, Doppler, Color | 7 | 2016 | 353 | 0.150 |
Why?
|
| Forms and Records Control | 2 | 2017 | 158 | 0.150 |
Why?
|
| Disease-Free Survival | 8 | 2017 | 6850 | 0.150 |
Why?
|
| Vasodilator Agents | 2 | 1998 | 988 | 0.150 |
Why?
|
| Fetal Diseases | 5 | 2010 | 915 | 0.150 |
Why?
|
| Verapamil | 1 | 1998 | 242 | 0.150 |
Why?
|
| Contrast Media | 2 | 2023 | 5329 | 0.150 |
Why?
|
| Cardiovascular Abnormalities | 3 | 2011 | 148 | 0.150 |
Why?
|
| Echocardiography, Doppler, Pulsed | 3 | 2014 | 68 | 0.140 |
Why?
|
| Sheep | 11 | 2000 | 1448 | 0.140 |
Why?
|
| Double-Blind Method | 11 | 2024 | 12430 | 0.140 |
Why?
|
| Methoxamine | 4 | 1985 | 45 | 0.140 |
Why?
|
| Catecholamines | 3 | 2016 | 388 | 0.140 |
Why?
|
| Critical Pathways | 2 | 2010 | 475 | 0.130 |
Why?
|
| Heart-Assist Devices | 4 | 2021 | 1287 | 0.130 |
Why?
|
| Recovery of Function | 4 | 2019 | 2976 | 0.130 |
Why?
|
| Sports | 2 | 1997 | 701 | 0.130 |
Why?
|
| Child Nutrition Disorders | 1 | 2018 | 139 | 0.130 |
Why?
|
| Analysis of Variance | 10 | 2018 | 6214 | 0.130 |
Why?
|
| Drug Administration Schedule | 7 | 2018 | 4853 | 0.130 |
Why?
|
| North America | 6 | 2017 | 1287 | 0.130 |
Why?
|
| Electrocardiography, Ambulatory | 10 | 2007 | 582 | 0.130 |
Why?
|
| Pacemaker, Artificial | 3 | 2012 | 828 | 0.130 |
Why?
|
| Quality-Adjusted Life Years | 2 | 2012 | 1740 | 0.130 |
Why?
|
| Blood Transfusion | 2 | 2018 | 1308 | 0.130 |
Why?
|
| Adaptation, Physiological | 5 | 2015 | 1313 | 0.130 |
Why?
|
| Employee Performance Appraisal | 1 | 2016 | 86 | 0.130 |
Why?
|
| Carrier Proteins | 5 | 2021 | 4924 | 0.130 |
Why?
|
| Cardiac Output | 6 | 2016 | 838 | 0.130 |
Why?
|
| Antihypertensive Agents | 2 | 2019 | 2030 | 0.130 |
Why?
|
| Peptide Fragments | 4 | 2013 | 5143 | 0.120 |
Why?
|
| Iron Chelating Agents | 2 | 2023 | 141 | 0.120 |
Why?
|
| Perinatal Care | 1 | 2017 | 244 | 0.120 |
Why?
|
| Catheter Ablation | 8 | 2007 | 2786 | 0.120 |
Why?
|
| Heart Rate | 11 | 2021 | 4207 | 0.120 |
Why?
|
| Receptors, Adrenergic | 1 | 2014 | 155 | 0.120 |
Why?
|
| Infusions, Intravenous | 7 | 2012 | 2228 | 0.120 |
Why?
|
| Pulmonary Circulation | 2 | 2015 | 744 | 0.120 |
Why?
|
| Diltiazem | 1 | 2014 | 132 | 0.110 |
Why?
|
| Time | 1 | 2016 | 550 | 0.110 |
Why?
|
| Fetal Therapies | 2 | 2006 | 101 | 0.110 |
Why?
|
| Neoplasms | 8 | 2024 | 22350 | 0.110 |
Why?
|
| Swimming | 3 | 1991 | 212 | 0.110 |
Why?
|
| Odds Ratio | 9 | 2015 | 9661 | 0.110 |
Why?
|
| Hypertension | 7 | 2002 | 8616 | 0.110 |
Why?
|
| Quality of Life | 6 | 2017 | 13476 | 0.110 |
Why?
|
| Case-Control Studies | 11 | 2022 | 22248 | 0.110 |
Why?
|
| Chi-Square Distribution | 7 | 2014 | 3432 | 0.110 |
Why?
|
| Stress, Mechanical | 7 | 2009 | 1674 | 0.110 |
Why?
|
| Creatine Kinase | 5 | 2006 | 683 | 0.110 |
Why?
|
| Anti-HIV Agents | 3 | 2012 | 4562 | 0.110 |
Why?
|
| Tricuspid Atresia | 1 | 2013 | 37 | 0.110 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2005 | 11872 | 0.110 |
Why?
|
| Cause of Death | 6 | 2018 | 3716 | 0.110 |
Why?
|
| Tissue and Organ Procurement | 1 | 2022 | 987 | 0.110 |
Why?
|
| Prevalence | 13 | 2018 | 15835 | 0.110 |
Why?
|
| Calcium Channels, L-Type | 1 | 2014 | 243 | 0.110 |
Why?
|
| Zalcitabine | 1 | 2012 | 43 | 0.100 |
Why?
|
| Dilatation | 3 | 2023 | 311 | 0.100 |
Why?
|
| Heterozygote | 3 | 2014 | 2795 | 0.100 |
Why?
|
| Logistic Models | 14 | 2015 | 13278 | 0.100 |
Why?
|
| Delivery of Health Care, Integrated | 2 | 2011 | 949 | 0.100 |
Why?
|
| Coronary Aneurysm | 1 | 2015 | 234 | 0.100 |
Why?
|
| Age of Onset | 4 | 2022 | 3342 | 0.100 |
Why?
|
| Cardiovascular Surgical Procedures | 1 | 2014 | 193 | 0.100 |
Why?
|
| Kidney Failure, Chronic | 3 | 2015 | 2505 | 0.100 |
Why?
|
| Dideoxynucleosides | 1 | 2013 | 135 | 0.100 |
Why?
|
| Australia | 4 | 2018 | 1263 | 0.100 |
Why?
|
| Middle Aged | 41 | 2021 | 223257 | 0.100 |
Why?
|
| Patient Selection | 6 | 2012 | 4252 | 0.100 |
Why?
|
| Immunoglobulins | 1 | 1995 | 853 | 0.100 |
Why?
|
| Models, Statistical | 3 | 2020 | 5091 | 0.100 |
Why?
|
| Decision Support Techniques | 3 | 2023 | 2006 | 0.100 |
Why?
|
| Exercise Tolerance | 3 | 2015 | 847 | 0.100 |
Why?
|
| Magnetic Resonance Imaging | 15 | 2018 | 36567 | 0.100 |
Why?
|
| History, 21st Century | 3 | 2017 | 1574 | 0.100 |
Why?
|
| Hemochromatosis | 1 | 2013 | 175 | 0.100 |
Why?
|
| Immunization, Passive | 3 | 1994 | 618 | 0.100 |
Why?
|
| Palliative Care | 9 | 2013 | 3640 | 0.100 |
Why?
|
| Matrix Metalloproteinase 3 | 1 | 2012 | 139 | 0.100 |
Why?
|
| Subclavian Artery | 1 | 1992 | 138 | 0.100 |
Why?
|
| Biopsy | 3 | 2020 | 6779 | 0.090 |
Why?
|
| Pulmonary Veno-Occlusive Disease | 1 | 2011 | 64 | 0.090 |
Why?
|
| Ventricular Fibrillation | 2 | 2012 | 538 | 0.090 |
Why?
|
| Costello Syndrome | 1 | 2011 | 19 | 0.090 |
Why?
|
| Hospital Costs | 3 | 2014 | 955 | 0.090 |
Why?
|
| Connecticut | 1 | 2011 | 365 | 0.090 |
Why?
|
| Myocardial Bridging | 1 | 2010 | 10 | 0.090 |
Why?
|
| Forecasting | 3 | 2017 | 2936 | 0.090 |
Why?
|
| Antineoplastic Agents | 4 | 2015 | 13643 | 0.090 |
Why?
|
| Early Termination of Clinical Trials | 1 | 2011 | 70 | 0.090 |
Why?
|
| Databases as Topic | 2 | 2012 | 472 | 0.090 |
Why?
|
| Comorbidity | 5 | 2012 | 10580 | 0.090 |
Why?
|
| Postoperative Care | 2 | 2016 | 1480 | 0.090 |
Why?
|
| Thyroid Hormone Resistance Syndrome | 2 | 2001 | 15 | 0.090 |
Why?
|
| Image Processing, Computer-Assisted | 4 | 2015 | 8926 | 0.090 |
Why?
|
| Troponin | 3 | 2010 | 536 | 0.090 |
Why?
|
| Corrosion Casting | 2 | 2000 | 15 | 0.090 |
Why?
|
| Ontario | 3 | 2017 | 404 | 0.090 |
Why?
|
| Hospital Mortality | 8 | 2013 | 5343 | 0.090 |
Why?
|
| Bone Neoplasms | 1 | 2023 | 2561 | 0.090 |
Why?
|
| Heart Arrest | 2 | 2020 | 1516 | 0.090 |
Why?
|
| Coronary Artery Disease | 4 | 2012 | 6558 | 0.090 |
Why?
|
| Silicone Elastomers | 2 | 2000 | 78 | 0.090 |
Why?
|
| Dextrocardia | 1 | 2010 | 37 | 0.090 |
Why?
|
| Vinblastine | 1 | 2011 | 482 | 0.090 |
Why?
|
| Transplantation | 1 | 2012 | 222 | 0.090 |
Why?
|
| Consensus Development Conferences as Topic | 1 | 2011 | 168 | 0.090 |
Why?
|
| History, 20th Century | 3 | 2017 | 2764 | 0.090 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 2 | 2023 | 5753 | 0.090 |
Why?
|
| Procollagen | 1 | 2010 | 189 | 0.080 |
Why?
|
| Wounds and Injuries | 2 | 2012 | 2513 | 0.080 |
Why?
|
| Electronic Health Records | 2 | 2017 | 4880 | 0.080 |
Why?
|
| Radiography | 7 | 2013 | 6968 | 0.080 |
Why?
|
| Child of Impaired Parents | 1 | 2013 | 462 | 0.080 |
Why?
|
| Anastomosis, Surgical | 5 | 2012 | 992 | 0.080 |
Why?
|
| Muscular Dystrophies | 2 | 2007 | 393 | 0.080 |
Why?
|
| Puerto Rico | 1 | 2010 | 380 | 0.080 |
Why?
|
| Postpartum Period | 1 | 1996 | 1195 | 0.080 |
Why?
|
| Cooperative Behavior | 1 | 2016 | 1512 | 0.080 |
Why?
|
| Regional Blood Flow | 2 | 2010 | 1478 | 0.080 |
Why?
|
| Databases, Genetic | 1 | 2016 | 1756 | 0.080 |
Why?
|
| Ferritins | 3 | 2023 | 601 | 0.080 |
Why?
|
| Pilot Projects | 8 | 2020 | 8728 | 0.080 |
Why?
|
| Cost of Illness | 1 | 2018 | 1949 | 0.080 |
Why?
|
| Intubation, Intratracheal | 1 | 2016 | 1359 | 0.080 |
Why?
|
| Models, Biological | 1 | 2004 | 9461 | 0.080 |
Why?
|
| Heart Valve Prosthesis Implantation | 2 | 2016 | 1564 | 0.080 |
Why?
|
| Tachycardia, Ventricular | 3 | 2012 | 1313 | 0.070 |
Why?
|
| Anti-Arrhythmia Agents | 2 | 2010 | 772 | 0.070 |
Why?
|
| Fever | 3 | 2013 | 1607 | 0.070 |
Why?
|
| Models, Theoretical | 1 | 2000 | 3561 | 0.070 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2018 | 2057 | 0.070 |
Why?
|
| Tachycardia | 4 | 2004 | 598 | 0.070 |
Why?
|
| Friedreich Ataxia | 1 | 2008 | 82 | 0.070 |
Why?
|
| Ablation Techniques | 1 | 2010 | 254 | 0.070 |
Why?
|
| Syncope | 1 | 2010 | 431 | 0.070 |
Why?
|
| Aorta, Abdominal | 1 | 2010 | 627 | 0.070 |
Why?
|
| Animals, Newborn | 3 | 2003 | 2677 | 0.070 |
Why?
|
| Abnormalities, Multiple | 4 | 2004 | 1424 | 0.070 |
Why?
|
| Standard of Care | 1 | 2011 | 569 | 0.070 |
Why?
|
| Diagnosis, Differential | 8 | 2007 | 12985 | 0.070 |
Why?
|
| Turner Syndrome | 1 | 2008 | 129 | 0.070 |
Why?
|
| Learning | 1 | 2016 | 1754 | 0.070 |
Why?
|
| Sex Factors | 7 | 2017 | 10619 | 0.070 |
Why?
|
| Renin-Angiotensin System | 1 | 2011 | 737 | 0.070 |
Why?
|
| Models, Molecular | 1 | 2016 | 5386 | 0.060 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2011 | 1244 | 0.060 |
Why?
|
| American Hospital Association | 1 | 2005 | 26 | 0.060 |
Why?
|
| Aged | 23 | 2023 | 171343 | 0.060 |
Why?
|
| Discriminant Analysis | 1 | 2006 | 222 | 0.060 |
Why?
|
| Age Distribution | 3 | 2014 | 2869 | 0.060 |
Why?
|
| Child Development | 2 | 2014 | 2327 | 0.060 |
Why?
|
| World Health Organization | 3 | 2021 | 1327 | 0.060 |
Why?
|
| ras Proteins | 1 | 2011 | 1055 | 0.060 |
Why?
|
| Consanguinity | 2 | 2006 | 460 | 0.060 |
Why?
|
| Methylprednisolone | 1 | 2007 | 387 | 0.060 |
Why?
|
| Cardiac Imaging Techniques | 2 | 2018 | 280 | 0.060 |
Why?
|
| Data Collection | 3 | 2023 | 3321 | 0.060 |
Why?
|
| Gestational Age | 8 | 2010 | 3617 | 0.060 |
Why?
|
| Advisory Committees | 3 | 2017 | 797 | 0.060 |
Why?
|
| Methotrexate | 1 | 2011 | 1719 | 0.060 |
Why?
|
| Body Surface Potential Mapping | 2 | 1997 | 228 | 0.060 |
Why?
|
| Daunorubicin | 1 | 1985 | 157 | 0.060 |
Why?
|
| Renal Dialysis | 3 | 2015 | 1790 | 0.060 |
Why?
|
| Drug Resistance | 1 | 2010 | 1592 | 0.060 |
Why?
|
| Isoenzymes | 3 | 2003 | 1688 | 0.060 |
Why?
|
| Disease Management | 1 | 2015 | 2533 | 0.060 |
Why?
|
| Reference Standards | 1 | 2008 | 1010 | 0.060 |
Why?
|
| Ebstein Anomaly | 1 | 2005 | 106 | 0.060 |
Why?
|
| Endocardial Fibroelastosis | 1 | 2005 | 66 | 0.060 |
Why?
|
| Career Choice | 1 | 2011 | 768 | 0.060 |
Why?
|
| Sports Medicine | 1 | 1987 | 239 | 0.060 |
Why?
|
| Axillary Artery | 1 | 1984 | 48 | 0.060 |
Why?
|
| Heart Block | 3 | 2004 | 391 | 0.060 |
Why?
|
| Ethanol | 1 | 2010 | 1326 | 0.060 |
Why?
|
| Coronary Disease | 4 | 2007 | 5915 | 0.060 |
Why?
|
| Sex Distribution | 2 | 2014 | 2274 | 0.060 |
Why?
|
| Pregnancy Trimester, Second | 3 | 1996 | 737 | 0.060 |
Why?
|
| Healthcare Disparities | 1 | 2020 | 3411 | 0.060 |
Why?
|
| Myopathy, Central Core | 1 | 2003 | 4 | 0.060 |
Why?
|
| Immunologic Factors | 2 | 2010 | 1594 | 0.060 |
Why?
|
| Health Resources | 1 | 2010 | 951 | 0.060 |
Why?
|
| MAP Kinase Signaling System | 1 | 2011 | 1491 | 0.060 |
Why?
|
| United Arab Emirates | 1 | 2003 | 42 | 0.060 |
Why?
|
| Weight Lifting | 3 | 1992 | 130 | 0.060 |
Why?
|
| Gene Expression Regulation | 1 | 2022 | 11920 | 0.060 |
Why?
|
| Oklahoma | 1 | 2003 | 36 | 0.050 |
Why?
|
| Vascular Resistance | 3 | 2016 | 939 | 0.050 |
Why?
|
| Southwestern United States | 1 | 2003 | 39 | 0.050 |
Why?
|
| Myosins | 2 | 2010 | 407 | 0.050 |
Why?
|
| Polymorphism, Genetic | 3 | 2020 | 4249 | 0.050 |
Why?
|
| Truncus Arteriosus | 1 | 2023 | 22 | 0.050 |
Why?
|
| Troponin I | 2 | 2014 | 659 | 0.050 |
Why?
|
| Intensive Care Units | 4 | 2013 | 3799 | 0.050 |
Why?
|
| Drug Therapy, Combination | 4 | 2018 | 6307 | 0.050 |
Why?
|
| Infant Welfare | 1 | 2003 | 78 | 0.050 |
Why?
|
| Rabbits | 3 | 2009 | 4752 | 0.050 |
Why?
|
| Intensive Care Units, Pediatric | 2 | 2016 | 1021 | 0.050 |
Why?
|
| Torticollis | 1 | 2003 | 69 | 0.050 |
Why?
|
| Information Storage and Retrieval | 1 | 2008 | 832 | 0.050 |
Why?
|
| Environmental Exposure | 1 | 2018 | 4554 | 0.050 |
Why?
|
| Hypopituitarism | 1 | 2005 | 253 | 0.050 |
Why?
|
| Acquired Immunodeficiency Syndrome | 4 | 1994 | 2205 | 0.050 |
Why?
|
| Endocarditis, Bacterial | 1 | 2007 | 436 | 0.050 |
Why?
|
| Mediastinum | 1 | 2004 | 272 | 0.050 |
Why?
|
| Mathematical Computing | 1 | 2003 | 142 | 0.050 |
Why?
|
| Anemia, Sickle Cell | 1 | 2011 | 1063 | 0.050 |
Why?
|
| Physical Exertion | 1 | 1985 | 667 | 0.050 |
Why?
|
| National Heart, Lung, and Blood Institute (U.S.) | 2 | 2017 | 325 | 0.050 |
Why?
|
| Blalock-Taussig Procedure | 2 | 2013 | 60 | 0.050 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2006 | 386 | 0.050 |
Why?
|
| Animals | 22 | 2020 | 168930 | 0.050 |
Why?
|
| Receptors, Thyroid Hormone | 2 | 2001 | 202 | 0.050 |
Why?
|
| Down Syndrome | 1 | 2010 | 916 | 0.050 |
Why?
|
| Uremia | 1 | 2003 | 202 | 0.050 |
Why?
|
| Quality Assurance, Health Care | 1 | 2012 | 2171 | 0.050 |
Why?
|
| Regression Analysis | 4 | 2007 | 6329 | 0.050 |
Why?
|
| Fourier Analysis | 1 | 2003 | 434 | 0.050 |
Why?
|
| Research Design | 5 | 2016 | 6207 | 0.050 |
Why?
|
| Captopril | 1 | 1982 | 261 | 0.050 |
Why?
|
| Phonocardiography | 3 | 1987 | 30 | 0.050 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2018 | 5690 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2018 | 10745 | 0.050 |
Why?
|
| Glucocorticoids | 2 | 2011 | 2158 | 0.050 |
Why?
|
| History, 19th Century | 2 | 2017 | 714 | 0.050 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2006 | 1331 | 0.050 |
Why?
|
| Enzyme Replacement Therapy | 1 | 2021 | 80 | 0.050 |
Why?
|
| Kidney Function Tests | 2 | 2015 | 685 | 0.050 |
Why?
|
| Statistics, Nonparametric | 2 | 2008 | 2846 | 0.050 |
Why?
|
| Feasibility Studies | 5 | 2012 | 5306 | 0.050 |
Why?
|
| Williams Syndrome | 1 | 2003 | 195 | 0.050 |
Why?
|
| Sudden Infant Death | 1 | 1984 | 293 | 0.050 |
Why?
|
| Safety | 1 | 2005 | 1157 | 0.050 |
Why?
|
| Quality of Health Care | 2 | 2020 | 4306 | 0.040 |
Why?
|
| Kyphosis | 1 | 2003 | 252 | 0.040 |
Why?
|
| Tachycardia, Paroxysmal | 2 | 1996 | 30 | 0.040 |
Why?
|
| Protein Precursors | 2 | 2018 | 1134 | 0.040 |
Why?
|
| Proline | 1 | 1982 | 454 | 0.040 |
Why?
|
| Pedigree | 3 | 2003 | 4539 | 0.040 |
Why?
|
| Constriction, Pathologic | 2 | 2022 | 1103 | 0.040 |
Why?
|
| Inflammation | 2 | 2018 | 10860 | 0.040 |
Why?
|
| Program Development | 3 | 2011 | 1297 | 0.040 |
Why?
|
| Aspirin | 2 | 2007 | 3135 | 0.040 |
Why?
|
| Pregnancy Outcome | 3 | 2007 | 2971 | 0.040 |
Why?
|
| New England | 1 | 2003 | 1059 | 0.040 |
Why?
|
| Infant, Low Birth Weight | 1 | 2005 | 870 | 0.040 |
Why?
|
| Myofibrils | 1 | 2020 | 143 | 0.040 |
Why?
|
| Muscle Relaxation | 1 | 2020 | 138 | 0.040 |
Why?
|
| Electrodes | 3 | 1997 | 610 | 0.040 |
Why?
|
| Blood Pressure Determination | 1 | 1983 | 646 | 0.040 |
Why?
|
| Edema | 1 | 2023 | 764 | 0.040 |
Why?
|
| Wisconsin | 1 | 2019 | 122 | 0.040 |
Why?
|
| Rheumatic Heart Disease | 1 | 2001 | 163 | 0.040 |
Why?
|
| CD4 Lymphocyte Count | 2 | 2012 | 2586 | 0.040 |
Why?
|
| Clinical Coding | 2 | 2011 | 187 | 0.040 |
Why?
|
| Mitochondria, Heart | 1 | 2000 | 229 | 0.040 |
Why?
|
| Child Welfare | 1 | 2003 | 521 | 0.040 |
Why?
|
| Fluoroscopy | 1 | 2003 | 948 | 0.040 |
Why?
|
| Hypotension | 1 | 1985 | 887 | 0.040 |
Why?
|
| Chelating Agents | 2 | 2014 | 380 | 0.040 |
Why?
|
| Vascular Fistula | 1 | 1999 | 50 | 0.040 |
Why?
|
| Medical Records Systems, Computerized | 1 | 2005 | 1196 | 0.040 |
Why?
|
| Lung | 2 | 2015 | 10067 | 0.040 |
Why?
|
| C-Reactive Protein | 3 | 2018 | 3853 | 0.040 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2002 | 553 | 0.040 |
Why?
|
| Mothers | 2 | 2023 | 2208 | 0.040 |
Why?
|
| Pulmonary Wedge Pressure | 1 | 2019 | 277 | 0.040 |
Why?
|
| Transplantation, Homologous | 3 | 2012 | 4860 | 0.040 |
Why?
|
| Acute Disease | 5 | 2011 | 7241 | 0.040 |
Why?
|
| Ventricular Septum | 1 | 2018 | 76 | 0.040 |
Why?
|
| Gadolinium | 1 | 2023 | 964 | 0.040 |
Why?
|
| Aortic Arch Syndromes | 1 | 1998 | 19 | 0.040 |
Why?
|
| Congresses as Topic | 2 | 2015 | 811 | 0.040 |
Why?
|
| Disease Models, Animal | 4 | 2003 | 18330 | 0.040 |
Why?
|
| Virus Diseases | 2 | 1994 | 720 | 0.040 |
Why?
|
| Monosaccharide Transport Proteins | 1 | 1999 | 437 | 0.040 |
Why?
|
| DiGeorge Syndrome | 1 | 1999 | 187 | 0.040 |
Why?
|
| Health Personnel | 1 | 2011 | 3384 | 0.040 |
Why?
|
| Anesthesia, General | 1 | 1985 | 1188 | 0.040 |
Why?
|
| Attitude of Health Personnel | 1 | 2011 | 3927 | 0.040 |
Why?
|
| Kidney Transplantation | 2 | 2015 | 4278 | 0.040 |
Why?
|
| Diagnostic Errors | 1 | 2005 | 1276 | 0.040 |
Why?
|
| Obesity | 1 | 2020 | 13090 | 0.040 |
Why?
|
| Denmark | 1 | 2019 | 777 | 0.040 |
Why?
|
| Physical Examination | 1 | 2003 | 1265 | 0.040 |
Why?
|
| AIDS Dementia Complex | 1 | 1998 | 154 | 0.030 |
Why?
|
| Cost Savings | 2 | 2014 | 902 | 0.030 |
Why?
|
| Insurance, Health | 1 | 2009 | 2520 | 0.030 |
Why?
|
| HIV-1 | 3 | 2002 | 6948 | 0.030 |
Why?
|
| Digoxin | 2 | 2012 | 246 | 0.030 |
Why?
|
| Serum | 1 | 2018 | 206 | 0.030 |
Why?
|
| Absorptiometry, Photon | 1 | 2023 | 1707 | 0.030 |
Why?
|
| Artifacts | 1 | 2005 | 1896 | 0.030 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2020 | 423 | 0.030 |
Why?
|
| Ethers | 1 | 1996 | 72 | 0.030 |
Why?
|
| Missouri | 1 | 2016 | 113 | 0.030 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2011 | 4056 | 0.030 |
Why?
|
| Endothelium, Vascular | 1 | 2009 | 4424 | 0.030 |
Why?
|
| Virulence | 1 | 2020 | 1294 | 0.030 |
Why?
|
| Fellowships and Scholarships | 1 | 2005 | 1134 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2018 | 10384 | 0.030 |
Why?
|
| Halothane | 1 | 1996 | 200 | 0.030 |
Why?
|
| Risk | 3 | 2002 | 9602 | 0.030 |
Why?
|
| Hodgkin Disease | 1 | 2004 | 1384 | 0.030 |
Why?
|
| Thyroid Hormones | 1 | 1999 | 408 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2020 | 1638 | 0.030 |
Why?
|
| Medicaid | 1 | 2009 | 2836 | 0.030 |
Why?
|
| Causality | 2 | 2016 | 1252 | 0.030 |
Why?
|
| Growth Disorders | 2 | 2011 | 634 | 0.030 |
Why?
|
| Milrinone | 1 | 2016 | 87 | 0.030 |
Why?
|
| Anesthesia, Inhalation | 1 | 1996 | 220 | 0.030 |
Why?
|
| Patient Admission | 1 | 2003 | 1364 | 0.030 |
Why?
|
| Nomograms | 1 | 2017 | 235 | 0.030 |
Why?
|
| Neuroblastoma | 1 | 2004 | 1266 | 0.030 |
Why?
|
| Preoperative Period | 1 | 2018 | 564 | 0.030 |
Why?
|
| Adenosine Triphosphatases | 1 | 2020 | 840 | 0.030 |
Why?
|
| Tachycardia, Ectopic Atrial | 1 | 1996 | 65 | 0.030 |
Why?
|
| Clinical Trials as Topic | 3 | 2006 | 8045 | 0.030 |
Why?
|
| Brazil | 1 | 2019 | 1249 | 0.030 |
Why?
|
| Vascular Diseases | 1 | 2004 | 1161 | 0.030 |
Why?
|
| Methyl Ethers | 1 | 1996 | 196 | 0.030 |
Why?
|
| Biomedical Research | 1 | 2011 | 3459 | 0.030 |
Why?
|
| Heart Conduction System | 2 | 2004 | 1007 | 0.030 |
Why?
|
| Running | 2 | 1992 | 488 | 0.030 |
Why?
|
| Receptors, Adrenergic, beta-1 | 1 | 2014 | 52 | 0.030 |
Why?
|
| Receptors, Adrenergic, alpha-2 | 1 | 2014 | 69 | 0.030 |
Why?
|
| Interprofessional Relations | 2 | 2011 | 998 | 0.030 |
Why?
|
| Massachusetts | 3 | 2012 | 8891 | 0.030 |
Why?
|
| Echocardiography, Transesophageal | 2 | 1998 | 1093 | 0.030 |
Why?
|
| DNA Mutational Analysis | 2 | 2017 | 4114 | 0.030 |
Why?
|
| Ohio | 1 | 2015 | 320 | 0.030 |
Why?
|
| Sample Size | 1 | 2017 | 844 | 0.030 |
Why?
|
| Recurrence | 4 | 2016 | 8507 | 0.030 |
Why?
|
| Fetal Death | 2 | 2006 | 434 | 0.030 |
Why?
|
| Pulmonary Subvalvular Stenosis | 1 | 1993 | 7 | 0.030 |
Why?
|
| Pregnancy Trimester, Third | 1 | 1996 | 587 | 0.030 |
Why?
|
| Education, Medical | 1 | 2005 | 1744 | 0.030 |
Why?
|
| Receptors, Adrenergic, beta-2 | 1 | 2014 | 216 | 0.030 |
Why?
|
| Ligation | 1 | 1994 | 446 | 0.030 |
Why?
|
| Elasticity | 1 | 2015 | 654 | 0.030 |
Why?
|
| Pulmonary Ventilation | 1 | 2015 | 375 | 0.030 |
Why?
|
| Decision Trees | 1 | 2015 | 508 | 0.030 |
Why?
|
| Heart Valve Prosthesis | 3 | 1997 | 1464 | 0.030 |
Why?
|
| Models, Organizational | 1 | 2016 | 548 | 0.030 |
Why?
|
| Prenatal Diagnosis | 3 | 1996 | 1271 | 0.030 |
Why?
|
| Coronary Angiography | 4 | 2012 | 4508 | 0.030 |
Why?
|
| Cell Enlargement | 1 | 2013 | 58 | 0.030 |
Why?
|
| Apoptosis | 1 | 2009 | 9513 | 0.030 |
Why?
|
| Prenatal Care | 1 | 2000 | 1158 | 0.030 |
Why?
|
| Dextrans | 2 | 1985 | 574 | 0.030 |
Why?
|
| Ultrasonography, Doppler | 1 | 1995 | 464 | 0.030 |
Why?
|
| Respiration, Artificial | 3 | 2012 | 2727 | 0.030 |
Why?
|
| Tachycardia, Atrioventricular Nodal Reentry | 1 | 1993 | 148 | 0.030 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2017 | 614 | 0.030 |
Why?
|
| Ploidies | 1 | 2013 | 287 | 0.020 |
Why?
|
| Tissue Inhibitor of Metalloproteinases | 1 | 2012 | 97 | 0.020 |
Why?
|
| Pituitary Neoplasms | 1 | 2001 | 1324 | 0.020 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2005 | 4047 | 0.020 |
Why?
|
| Cost-Benefit Analysis | 2 | 2016 | 5536 | 0.020 |
Why?
|
| Status Asthmaticus | 1 | 1991 | 21 | 0.020 |
Why?
|
| Protein Conformation | 1 | 2020 | 3947 | 0.020 |
Why?
|
| Tissue Donors | 1 | 2022 | 2392 | 0.020 |
Why?
|
| Matrix Metalloproteinase 1 | 1 | 2012 | 147 | 0.020 |
Why?
|
| Pregnancy Trimester, First | 1 | 1996 | 917 | 0.020 |
Why?
|
| Cardiac Output, Low | 1 | 1992 | 192 | 0.020 |
Why?
|
| Monitoring, Intraoperative | 1 | 1998 | 947 | 0.020 |
Why?
|
| gamma-Globulins | 1 | 1991 | 119 | 0.020 |
Why?
|
| Anesthetics, Inhalation | 1 | 1996 | 573 | 0.020 |
Why?
|
| Isoproterenol | 1 | 1991 | 398 | 0.020 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2016 | 606 | 0.020 |
Why?
|
| Stroke | 3 | 2020 | 9741 | 0.020 |
Why?
|
| Metabolism, Inborn Errors | 1 | 2013 | 291 | 0.020 |
Why?
|
| Genetic Markers | 1 | 2017 | 2603 | 0.020 |
Why?
|
| Atrophy | 1 | 1996 | 1631 | 0.020 |
Why?
|
| Combined Modality Therapy | 2 | 2018 | 8540 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2004 | 6259 | 0.020 |
Why?
|
| Graft Survival | 1 | 2022 | 3904 | 0.020 |
Why?
|
| Postmortem Changes | 1 | 2011 | 119 | 0.020 |
Why?
|
| Protamines | 1 | 1991 | 112 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 2016 | 3053 | 0.020 |
Why?
|
| Motion | 1 | 1994 | 783 | 0.020 |
Why?
|
| Clinical Protocols | 1 | 2016 | 1437 | 0.020 |
Why?
|
| Angiotensins | 1 | 2011 | 140 | 0.020 |
Why?
|
| Texas | 1 | 2011 | 410 | 0.020 |
Why?
|
| Thyrotropin-Releasing Hormone | 2 | 2001 | 139 | 0.020 |
Why?
|
| Signal Processing, Computer-Assisted | 2 | 1997 | 1457 | 0.020 |
Why?
|
| Sequence Deletion | 1 | 2014 | 1494 | 0.020 |
Why?
|
| DNA Primers | 1 | 2014 | 2826 | 0.020 |
Why?
|
| Adenoma | 1 | 2001 | 2155 | 0.020 |
Why?
|
| Administration, Oral | 1 | 1998 | 4018 | 0.020 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 2 | 2004 | 511 | 0.020 |
Why?
|
| Sex Characteristics | 1 | 2020 | 2645 | 0.020 |
Why?
|
| Survival | 1 | 2010 | 160 | 0.020 |
Why?
|
| Lactates | 1 | 1991 | 398 | 0.020 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2012 | 461 | 0.020 |
Why?
|
| Early Diagnosis | 1 | 2015 | 1186 | 0.020 |
Why?
|
| Myofibroblasts | 1 | 2011 | 230 | 0.020 |
Why?
|
| Random Allocation | 2 | 1996 | 2394 | 0.020 |
Why?
|
| Body Mass Index | 2 | 2020 | 13050 | 0.020 |
Why?
|
| Tropomyosin | 1 | 2010 | 105 | 0.020 |
Why?
|
| Cancer Care Facilities | 1 | 2012 | 428 | 0.020 |
Why?
|
| Health Services Accessibility | 2 | 2020 | 5514 | 0.020 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2011 | 326 | 0.020 |
Why?
|
| Arterio-Arterial Fistula | 1 | 1989 | 20 | 0.020 |
Why?
|
| Genetic Counseling | 1 | 2013 | 634 | 0.020 |
Why?
|
| Intention to Treat Analysis | 1 | 2010 | 418 | 0.020 |
Why?
|
| Portraits as Topic | 1 | 2008 | 33 | 0.020 |
Why?
|
| Viral Load | 2 | 2013 | 3385 | 0.020 |
Why?
|
| Nutritional Status | 1 | 1997 | 1621 | 0.020 |
Why?
|
| Cells, Cultured | 2 | 2020 | 18984 | 0.020 |
Why?
|
| Evidence-Based Medicine | 2 | 2011 | 3692 | 0.020 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2012 | 633 | 0.020 |
Why?
|
| Renin | 1 | 2011 | 647 | 0.020 |
Why?
|
| Energy Metabolism | 1 | 2020 | 2903 | 0.020 |
Why?
|
| Blood Chemical Analysis | 1 | 2010 | 434 | 0.020 |
Why?
|
| Chronic Disease | 3 | 2012 | 9357 | 0.020 |
Why?
|
| Organizational Objectives | 1 | 2010 | 426 | 0.020 |
Why?
|
| Angiocardiography | 1 | 1988 | 149 | 0.020 |
Why?
|
| Prolactin | 2 | 2001 | 627 | 0.020 |
Why?
|
| Educational Status | 1 | 2015 | 2510 | 0.020 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2020 | 1882 | 0.020 |
Why?
|
| Methods | 1 | 1988 | 1065 | 0.020 |
Why?
|
| International Cooperation | 2 | 2005 | 1434 | 0.020 |
Why?
|
| Hyperemia | 1 | 2009 | 223 | 0.020 |
Why?
|
| Pressure | 3 | 1988 | 1172 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2014 | 3624 | 0.020 |
Why?
|
| Blood Vessel Prosthesis | 1 | 1992 | 956 | 0.020 |
Why?
|
| Infant Mortality | 1 | 2012 | 751 | 0.020 |
Why?
|
| Pulse Therapy, Drug | 1 | 2007 | 37 | 0.020 |
Why?
|
| Drug Monitoring | 1 | 2013 | 962 | 0.020 |
Why?
|
| England | 1 | 2008 | 533 | 0.020 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2015 | 996 | 0.020 |
Why?
|
| Leukocyte Count | 1 | 2011 | 1606 | 0.020 |
Why?
|
| Brachial Artery | 1 | 2009 | 373 | 0.020 |
Why?
|
| Income | 1 | 2015 | 1875 | 0.020 |
Why?
|
| Collagen Type I | 1 | 2010 | 616 | 0.020 |
Why?
|
| Health Care Rationing | 1 | 2010 | 435 | 0.020 |
Why?
|
| Congenital Abnormalities | 1 | 1991 | 703 | 0.020 |
Why?
|
| Caspase 3 | 1 | 2009 | 730 | 0.020 |
Why?
|
| Thyrotropin | 2 | 2001 | 834 | 0.020 |
Why?
|
| Cell Proliferation | 2 | 2013 | 10445 | 0.020 |
Why?
|
| Abortion, Therapeutic | 1 | 2006 | 35 | 0.020 |
Why?
|
| Myocardial Ischemia | 2 | 1994 | 2132 | 0.020 |
Why?
|
| Adaptation, Biological | 1 | 1987 | 147 | 0.020 |
Why?
|
| Aldosterone | 1 | 2011 | 881 | 0.020 |
Why?
|
| Atrial Appendage | 1 | 2010 | 285 | 0.020 |
Why?
|
| Office Visits | 1 | 2010 | 593 | 0.020 |
Why?
|
| Liver | 2 | 2018 | 7571 | 0.020 |
Why?
|
| Comprehension | 1 | 2011 | 638 | 0.020 |
Why?
|
| Psychomotor Performance | 1 | 2014 | 1885 | 0.020 |
Why?
|
| Fingers | 1 | 2009 | 508 | 0.020 |
Why?
|
| Leukopenia | 1 | 2006 | 213 | 0.020 |
Why?
|
| Medical Records | 2 | 2002 | 1408 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2022 | 9525 | 0.020 |
Why?
|
| Lactic Acid | 1 | 1991 | 1139 | 0.020 |
Why?
|
| Twins, Conjoined | 1 | 1985 | 41 | 0.020 |
Why?
|
| Dwarfism | 1 | 2006 | 137 | 0.020 |
Why?
|
| Evaluation Studies as Topic | 3 | 1993 | 1622 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2016 | 8106 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2012 | 3804 | 0.010 |
Why?
|
| Cell Count | 1 | 2009 | 1826 | 0.010 |
Why?
|
| Deferoxamine | 1 | 1985 | 155 | 0.010 |
Why?
|
| Body Weight | 2 | 2010 | 4626 | 0.010 |
Why?
|
| Cell Cycle | 1 | 2013 | 2926 | 0.010 |
Why?
|
| Acyltransferases | 1 | 2006 | 305 | 0.010 |
Why?
|
| Monitoring, Physiologic | 3 | 1989 | 1794 | 0.010 |
Why?
|
| Task Performance and Analysis | 1 | 2008 | 771 | 0.010 |
Why?
|
| Myocardial Perfusion Imaging | 1 | 2010 | 669 | 0.010 |
Why?
|
| Aged, 80 and over | 4 | 2012 | 59550 | 0.010 |
Why?
|
| Cardiac Complexes, Premature | 1 | 1984 | 63 | 0.010 |
Why?
|
| Prealbumin | 1 | 2006 | 259 | 0.010 |
Why?
|
| Radiotherapy | 1 | 2011 | 1497 | 0.010 |
Why?
|
| Weight Gain | 1 | 2014 | 2356 | 0.010 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2015 | 1481 | 0.010 |
Why?
|
| Regeneration | 1 | 2013 | 1520 | 0.010 |
Why?
|
| Radiography, Thoracic | 1 | 2010 | 1320 | 0.010 |
Why?
|
| Base Sequence | 1 | 2014 | 12415 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2014 | 4780 | 0.010 |
Why?
|
| Confidence Intervals | 1 | 2009 | 2921 | 0.010 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2006 | 633 | 0.010 |
Why?
|
| Blood Urea Nitrogen | 1 | 2003 | 189 | 0.010 |
Why?
|
| Hand Strength | 1 | 2006 | 464 | 0.010 |
Why?
|
| Muscle Weakness | 1 | 2006 | 412 | 0.010 |
Why?
|
| Cytokines | 1 | 2018 | 7438 | 0.010 |
Why?
|
| Arteriovenous Shunt, Surgical | 1 | 2006 | 291 | 0.010 |
Why?
|
| Probability | 1 | 2008 | 2476 | 0.010 |
Why?
|
| Wolff-Parkinson-White Syndrome | 1 | 1984 | 117 | 0.010 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2011 | 1762 | 0.010 |
Why?
|
| Syndrome | 2 | 2006 | 3271 | 0.010 |
Why?
|
| HIV Seronegativity | 1 | 2004 | 209 | 0.010 |
Why?
|
| Creatine Kinase, MB Form | 1 | 2003 | 203 | 0.010 |
Why?
|
| Health Services Research | 1 | 2010 | 1811 | 0.010 |
Why?
|
| Medical History Taking | 1 | 2006 | 779 | 0.010 |
Why?
|
| Fibrinolytic Agents | 1 | 2012 | 2078 | 0.010 |
Why?
|
| Growth | 1 | 2004 | 365 | 0.010 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 1 | 2004 | 416 | 0.010 |
Why?
|
| Education, Medical, Continuing | 1 | 2008 | 830 | 0.010 |
Why?
|
| Spinal Fusion | 1 | 1992 | 1307 | 0.010 |
Why?
|
| Digitoxin | 1 | 1982 | 19 | 0.010 |
Why?
|
| Peritoneal Dialysis | 1 | 2003 | 161 | 0.010 |
Why?
|
| Collagen | 1 | 2010 | 2635 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2011 | 4142 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2014 | 17608 | 0.010 |
Why?
|
| Bradycardia | 1 | 1984 | 304 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 1999 | 9244 | 0.010 |
Why?
|
| Program Evaluation | 1 | 2010 | 2504 | 0.010 |
Why?
|
| Genetic Association Studies | 1 | 2011 | 2746 | 0.010 |
Why?
|
| Manometry | 1 | 1984 | 458 | 0.010 |
Why?
|
| Thorax | 1 | 2004 | 555 | 0.010 |
Why?
|
| Multicenter Studies as Topic | 1 | 2006 | 1733 | 0.010 |
Why?
|
| Guideline Adherence | 1 | 2011 | 2234 | 0.010 |
Why?
|
| Neuropsychological Tests | 1 | 2014 | 7119 | 0.010 |
Why?
|
| Neovascularization, Pathologic | 1 | 1991 | 2631 | 0.010 |
Why?
|
| Baltimore | 1 | 2001 | 233 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 2014 | 7841 | 0.010 |
Why?
|
| Alcohol Drinking | 1 | 2013 | 4045 | 0.010 |
Why?
|
| Rats | 1 | 2016 | 23717 | 0.010 |
Why?
|
| Cardiac Pacing, Artificial | 2 | 1997 | 881 | 0.010 |
Why?
|
| Pituitary Gland, Anterior | 1 | 1999 | 142 | 0.010 |
Why?
|
| Cadaver | 1 | 2004 | 1362 | 0.010 |
Why?
|
| Data Interpretation, Statistical | 1 | 2008 | 2693 | 0.010 |
Why?
|
| Movement | 1 | 2005 | 1468 | 0.010 |
Why?
|
| Pain Measurement | 1 | 2009 | 3576 | 0.010 |
Why?
|
| Diuretics | 1 | 2001 | 614 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2003 | 1716 | 0.010 |
Why?
|
| Peptides | 1 | 2010 | 4344 | 0.010 |
Why?
|
| RNA, Viral | 2 | 2001 | 2867 | 0.010 |
Why?
|
| Mental Processes | 1 | 1999 | 242 | 0.010 |
Why?
|
| Cross-Over Studies | 1 | 2004 | 2108 | 0.010 |
Why?
|
| Intraoperative Complications | 1 | 1985 | 1171 | 0.010 |
Why?
|
| Critical Care | 1 | 2010 | 2714 | 0.010 |
Why?
|
| Infant, Premature, Diseases | 1 | 1984 | 712 | 0.010 |
Why?
|
| Radiotherapy Dosage | 1 | 2004 | 2911 | 0.010 |
Why?
|
| Dogs | 1 | 1982 | 3834 | 0.010 |
Why?
|
| Pericardial Effusion | 1 | 1999 | 246 | 0.010 |
Why?
|
| Atrial Function, Right | 1 | 1997 | 32 | 0.010 |
Why?
|
| Equipment Design | 2 | 1997 | 3487 | 0.010 |
Why?
|
| Ecchymosis | 1 | 1997 | 32 | 0.010 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2007 | 2270 | 0.010 |
Why?
|
| Cholesterol, LDL | 1 | 2006 | 2392 | 0.010 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2004 | 1935 | 0.010 |
Why?
|
| Calcium | 1 | 2010 | 5783 | 0.010 |
Why?
|
| Embolism, Air | 1 | 1997 | 111 | 0.010 |
Why?
|
| Ethics, Medical | 1 | 2001 | 785 | 0.010 |
Why?
|
| Smoking | 1 | 2013 | 9077 | 0.010 |
Why?
|
| Point Mutation | 1 | 2001 | 1591 | 0.010 |
Why?
|
| Infant, Premature | 1 | 2005 | 2120 | 0.010 |
Why?
|
| Atrial Flutter | 1 | 1997 | 253 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2004 | 6507 | 0.010 |
Why?
|
| Immune Tolerance | 1 | 2004 | 2325 | 0.010 |
Why?
|
| Hypothalamus | 1 | 1999 | 1003 | 0.010 |
Why?
|
| Cineangiography | 1 | 1993 | 108 | 0.010 |
Why?
|
| Electrophysiology | 1 | 1997 | 1263 | 0.010 |
Why?
|
| Equipment Safety | 1 | 1995 | 250 | 0.010 |
Why?
|
| Technetium Tc 99m Sestamibi | 1 | 1994 | 185 | 0.010 |
Why?
|
| HIV Antibodies | 1 | 2000 | 1337 | 0.010 |
Why?
|
| Calcium-Transporting ATPases | 1 | 1993 | 122 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2012 | 16044 | 0.010 |
Why?
|
| Atherosclerosis | 1 | 2009 | 3420 | 0.010 |
Why?
|
| Mice | 1 | 2020 | 81889 | 0.010 |
Why?
|
| Delivery of Health Care | 1 | 2010 | 5368 | 0.010 |
Why?
|
| Decision Making | 1 | 2006 | 3951 | 0.010 |
Why?
|
| Wheelchairs | 1 | 1992 | 78 | 0.010 |
Why?
|
| Proteins | 1 | 2006 | 6002 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 2006 | 4970 | 0.010 |
Why?
|
| Cicatrix | 1 | 1997 | 798 | 0.010 |
Why?
|
| Microcirculation | 1 | 1994 | 1282 | 0.010 |
Why?
|
| Vasoconstriction | 1 | 1992 | 592 | 0.010 |
Why?
|
| Autoradiography | 1 | 1990 | 725 | 0.010 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1990 | 1305 | 0.000 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 1994 | 1143 | 0.000 |
Why?
|
| Intraoperative Care | 1 | 1992 | 768 | 0.000 |
Why?
|
| Angiography | 1 | 1993 | 1595 | 0.000 |
Why?
|
| Capillaries | 1 | 1991 | 755 | 0.000 |
Why?
|
| False Negative Reactions | 1 | 1988 | 570 | 0.000 |
Why?
|
| Transcription Factors | 1 | 2006 | 12150 | 0.000 |
Why?
|
| Thermodilution | 1 | 1986 | 50 | 0.000 |
Why?
|
| Wound Healing | 1 | 1997 | 2800 | 0.000 |
Why?
|
| Vena Cava, Inferior | 1 | 1988 | 463 | 0.000 |
Why?
|
| Calcinosis | 1 | 1994 | 1480 | 0.000 |
Why?
|
| False Positive Reactions | 1 | 1988 | 957 | 0.000 |
Why?
|
| Pediatric Nursing | 1 | 1986 | 104 | 0.000 |
Why?
|
| Fibroblast Growth Factors | 1 | 1991 | 871 | 0.000 |
Why?
|
| Computers | 1 | 1986 | 589 | 0.000 |
Why?
|
| Injections, Subcutaneous | 1 | 1985 | 684 | 0.000 |
Why?
|
| Aspartate Aminotransferases | 1 | 1985 | 416 | 0.000 |
Why?
|
| Swine | 1 | 1993 | 5987 | 0.000 |
Why?
|
| DNA, Viral | 1 | 1990 | 2201 | 0.000 |
Why?
|
| Anesthesia | 1 | 1992 | 1595 | 0.000 |
Why?
|
| Immunoglobulin G | 1 | 1991 | 4559 | 0.000 |
Why?
|
| RNA, Messenger | 1 | 1993 | 12791 | 0.000 |
Why?
|
| Patient Compliance | 1 | 1985 | 2694 | 0.000 |
Why?
|